Automated Peritoneal Dialysis Market Report 2026

The automated peritoneal dialysis market size has grown strongly in recent years. It will grow from $2.36 billion in 2025 to $2.56 billion in 2026 at a compound annual growth rate (CAGR) of 8.7%. The growth in the historic period can be attributed to rising prevalence of chronic kidney disease, growing demand for home-based dialysis, increasing adoption of automated peritoneal dialysis, rising geriatric population prone to renal complications, and expansion of patient awareness and education about APD.

The automated peritoneal dialysis market size is expected to see strong growth in the next few years. It will grow to $3.53 billion in 2030 at a compound annual growth rate (CAGR) of 8.3%. The growth in the forecast period can be attributed to increasing focus on patient-centric care, rising adoption of hybrid and portable APD systems, growing investments in research and development, expansion of home dialysis programs in emerging markets, and increasing healthcare expenditure and reimbursement support. Major trends in the forecast period include advancement in automated cycler technology, technology integration with telehealth and remote monitoring, innovation in disposable sets and consumables, research and development in biocompatible PD solutions,and integration of data analytics and AI-based treatment optimization.

The rising prevalence of chronic kidney disease is expected to propel the growth of the automated peritoneal dialysis market going forward. Chronic kidney disease refers to a long-term condition in which the kidneys do not function effectively, resulting in the buildup of waste products and excess fluids in the body. The prevalence of chronic kidney disease is increasing largely due to the rising incidence of diabetes and high blood pressure, as these conditions progressively damage kidney blood vessels and impair the organs’ ability to filter waste efficiently. Automated peritoneal dialysis supports the management of chronic kidney disease by delivering precise, pre-programmed dialysis treatments with minimal manual intervention, often during sleep. It improves patient outcomes by enhancing treatment consistency, reducing caregiver burden, and enabling a better quality of life through flexible home-based care. For instance, in June 2023, according to Kidney Research UK, a United Kingdom-based non-profit organization, approximately 7.2 million people in the United Kingdom were living with chronic kidney disease, representing over 10% of the population, of which 3.25 million were in advanced stages and 3.9 million were in early stages, with the total number of affected individuals projected to increase to 7.61 million by 2033. Therefore, the rising prevalence of chronic kidney disease is driving the growth of the automated peritoneal dialysis market.

Leading companies operating in the automated peritoneal dialysis market are focusing on developing advanced renal therapy solutions, such as automated peritoneal dialysis (APD) systems, to improve patient outcomes, reduce caregiver burden, and support home-based kidney care. An automated peritoneal dialysis system refers to a machine that automatically performs dialysis exchanges, typically overnight, by regulating fluid inflow and outflow based on programmed treatment prescriptions, thereby enhancing convenience, safety, and adherence compared with manual dialysis. For instance, in May 2025, By Onyks Inc., a US-based medical device company, received FDA 510(k) clearance for its X1 automated peritoneal dialysis (APD) cycler designed to transform chronic kidney disease management. The automated peritoneal dialysis system combines user-friendly automation with precise control of dwell times, fluid volumes, and treatment cycles to support individualized therapy plans while minimizing patient and caregiver effort. The launch highlights the growing adoption of connected, automated dialysis technologies that enable efficient treatment delivery in both clinical and home settings.

In July 2025, Vantive Medical Technologies LLC, a US-based innovator in home dialysis systems, partnered with Innovative Renal Care Inc. to expand the use of technology in home dialysis therapies. Through this collaboration, Vantive Medical Technologies LLC and Innovative Renal Care Inc. aim to integrate connected digital tools, remote monitoring, and IoT-enabled device capabilities into home dialysis workflows to improve patient outcomes, support care teams, and facilitate more personalized therapy management. Innovative Renal Care Inc. is a US-based provider of end-to-end kidney care.

Major companies operating in the automated peritoneal dialysis market are Fresenius Medical Care, Asahi Kasei Medical Co. Ltd., Toray Industries, Baxter International, DaVita Inc., Terumo Corporation, Diaverum AB, WEGO Blood Purification, Satellite Healthcare, JMS Co. Ltd., Zhejiang Tiancheng Medical Technology Co. Ltd, Kawasumi Laboratories Inc., Weigao Group, Mitra Industries Pvt. Ltd., Infomed Fluids S.r.l., Debiotech, Medionics International Inc, Renax Biomedical Tech Co. Ltd., Shenzhen Shenkang Medtech Co. Ltd., Newsol Technologies Inc., Shenzhen Landwind Industry Co. Ltd.

North America was the largest region in the automated peritoneal dialysis market in 2025. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the automated peritoneal dialysis market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa. The countries covered in the automated peritoneal dialysis market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report’s Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

Tariffs have affected the automated peritoneal dialysis market by increasing the cost of imported cyclers, dialysis solutions, and components, leading to higher overall treatment costs. the home-use and portable cycler segments are most impacted, particularly in regions reliant on imports like north america and europe. while tariffs create cost challenges, they also encourage local manufacturing and innovation in more cost-efficient dialysis solutions, potentially strengthening domestic production capabilities.

Automated peritoneal dialysis (APD) is a renal replacement therapy that utilizes a machine to automatically carry out dialysis cycles, typically during the patient’s sleep. The system fills and drains the peritoneal cavity with dialysis fluid to eliminate waste products and excess fluids from the body. Its primary objective is to deliver convenient, efficient, and continuous kidney support for patients with renal failure. APD enhances quality of life by minimizing the need for manual exchanges and frequent hospital visits.

The primary product types of automated peritoneal dialysis systems include cyclers, dialysis solutions, and accessories. Cyclers are automated machines that control fluid exchanges, dwell times, and drainage to support efficient home-based peritoneal dialysis. These systems address conditions such as end-stage renal disease and chronic kidney disease and are used for treatment, training and education, and research and development across hospitals, clinics, and home care environments.

The automated peritoneal dialysis market includes revenues earned by entities through remote patient monitoring, dialysis treatment management, machine setup and operation support, telehealth consultations, patient training and education, real-time data analysis, and maintenance and technical support. The market value includes the value of related goods sold by the service provider or included within the service offering. Only goods and services traded between entities or sold to end consumers are included.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

This product will be delivered within 1-3 business days.